top of page

Dennis Calvert, CEO of BioLargo, Inc., Returns to Uptick Newswire’s Stock Day Podcast

Dennis Calvert, CEO of BioLargo, Inc., Returns to Uptick Newswire’s Stock Day Podcast to Discuss Company’s Continued Commercial Progress

PHOENIX, June 11, 2018 (GLOBE NEWSWIRE) — Dennis Calvert, CEO of BioLargo, Inc. (OTCQB:BLGO) (BioLargo, BLGO, the “Company”) recently spoke with “Stock Day” host Everett Jolly about the company’s commercial progress.

BioLargo, Inc. is a dynamic technology incubator and environmental engineering company that develops innovative technology solutions for industry with a focus on clean air, clean water and advanced wound care. The company’s structure is unique: their in-house team of scientists and engineers invent, prove, and develop the company’s rich portfolio of platform technologies, which can then be monetized through direct-to-market, licensing, partnership and spin-out strategies.

Dennis Calvert discussed the company’s first big commercial success with their industrial odor control product, CupriDyne Clean®, sold to solid waste management facilities, landfills, transfer stations, and recycling centers. The company is also finding early success for the product with wastewater treatment facilities. The Company estimates there are 16,000 public wastewater treatment facilities operating in the United States. In the interview, Calvert commented, “There’s no reason every one of them couldn’t use our product – the trick is that they have to know about it.” He claims the product has proven to be extremely effective, and logistics are the only thing keeping it from being used by a wider client base.

In addition to CupriDyne Clean®, BioLargo has several other products in the works that could be released in the near future. These incubating technologies represent some of the company’s biggest potential market disruptors. One of its most important is its Advanced Oxidation System (AOS), a highly innovative water disinfection and decontamination system created to provide affordable, energy-efficient clean water for places and industries in need.  Its advanced wound care products are in process with the FDA under the 510(k) medical device classification, representing an important milestone in the journey to commercialization.

The company has seen increased revenue in past quarters and expects this trend to continue. Calvert commented, “We really had to do significant work to get this technology adopted, and we’re not done…we are on the uptick. This is the moment when the transformation of the company can be witnessed on a monthly basis as we mold into a full-service company, solving real life problems for clients. That’s about as good as it gets.”

For more information about BioLargo’s marketing strategies, product updates, and the company’s systematic adoption strategies, listen to the full interview at the link below.

BioLargo also regularly posts information regarding specific projects and technologies on a blog, at this link:

About BioLargo, Inc.

BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to expedite them from “cradle” to “maturity” ( Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship ( Our industrial odor control division, Odor-No-More ( features CupriDyne Clean Industrial Odor Eliminator (, which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water ( develops the Advanced Oxidation System “AOS”, a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical ( features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Contact Information Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2

About Uptick Newswire and the “Stock Day Podcast”

Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the under-valued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona.

Recent Posts

See All


bottom of page